[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$repl](/topic/$repl)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$repl/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$repl/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-06-24  

**Most Supportive Themes**
- **FDA Approval and Price Target:** (60%) Positive sentiment around potential FDA approval of RP1 plus nivolumab and the potential for increased sales.
- **Breakout and Buy Zone Potential:** (30%) Mentions of $REPL in conjunction with other stocks, indicating potential breakout setups and buy-zone potentials.
  
**Most Critical Themes**
- **Volatility and Trial Concerns:** (10%)  Concerns about the lack of a randomized trial for RP1 plus nivolumab and the potential for volatility.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | X        | X% |